[HTML][HTML] Cloud-based system for effective surveillance and control of COVID-19: useful experiences from Hubei, China
M Gong, L Liu, X Sun, Y Yang, S Wang… - Journal of medical Internet …, 2020 - jmir.org
Background Coronavirus disease (COVID-19) has been an unprecedented challenge to the
global health care system. Tools that can improve the focus of surveillance efforts and …
global health care system. Tools that can improve the focus of surveillance efforts and …
[HTML][HTML] Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France …
…, S Fernandez-Bertolin, S Fortin, A Golozar, M Gong… - Medrxiv, 2020 - ncbi.nlm.nih.gov
Objectives To characterize the demographics, comorbidities, symptoms, in-hospital treatments,
and health outcomes among children/adolescents diagnosed or hospitalized with COVID-…
and health outcomes among children/adolescents diagnosed or hospitalized with COVID-…
[HTML][HTML] Use of clinical data interchange standards consortium (CDISC) standards for real-world data: expert perspectives from a qualitative Delphi survey
R Facile, EE Muhlbradt, M Gong, Q Li… - JMIR medical …, 2022 - medinform.jmir.org
Background Real-world data (RWD) and real-world evidence (RWE) are playing increasingly
important roles in clinical research and health care decision-making. To leverage RWD …
important roles in clinical research and health care decision-making. To leverage RWD …
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study
Objective To investigate the use of repurposed and adjuvant drugs in patients admitted to
hospital with covid-19 across three continents. Design Multinational network cohort study. …
hospital with covid-19 across three continents. Design Multinational network cohort study. …
[HTML][HTML] Development and validation of a deep learning-based model using computed tomography imaging for predicting disease severity of coronavirus disease …
…, YL He, WF Zhang, SC Ma, C Hu, M Gong… - … in bioengineering and …, 2020 - frontiersin.org
Objectives Coronavirus disease 2019 (COVID-19) is sweeping the globe and has resulted
in infections in millions of people. Patients with COVID-19 face a high fatality risk once …
in infections in millions of people. Patients with COVID-19 face a high fatality risk once …
Thirty-day outcomes of children and adolescents with COVID-19: an international experience
…, S Fortin, A Golozar, M Gong… - …, 2021 - publications.aap.org
OBJECTIVES To characterize the demographics, comorbidities, symptoms, in-hospital
treatments, and health outcomes among children and adolescents diagnosed or hospitalized with …
treatments, and health outcomes among children and adolescents diagnosed or hospitalized with …
[HTML][HTML] State of the art of machine learning–enabled clinical decision support in intensive care units: Literature review
…, C Liu, J Gao, L Han, F Chang, M Gong… - JMIR Medical …, 2022 - medinform.jmir.org
Background Modern clinical care in intensive care units is full of rich data, and machine
learning has great potential to support clinical decision-making. The development of intelligent …
learning has great potential to support clinical decision-making. The development of intelligent …
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries
Objective Patients with autoimmune diseases were advised to shield to avoid coronavirus
disease 2019 (COVID-19), but information on their prognosis is lacking. We characterized 30-…
disease 2019 (COVID-19), but information on their prognosis is lacking. We characterized 30-…
[HTML][HTML] Access and unmet needs of orphan drugs in 194 countries and 6 areas: a global policy review with content analysis
Objectives Three hundred million people living with rare diseases worldwide are
disproportionately deprived of in-time diagnosis and treatment compared with other patients. This …
disproportionately deprived of in-time diagnosis and treatment compared with other patients. This …
[HTML][HTML] Barriers and considerations for diagnosing rare diseases in indigenous populations
…, GM Repetto, G Mengchun… - Frontiers in …, 2020 - frontiersin.org
Advances in omics and specifically genomic technologies are increasingly transforming
rare disease diagnosis. However, the benefits of these advances are disproportionately …
rare disease diagnosis. However, the benefits of these advances are disproportionately …
